tert-butyl 3-((benzo[d]thiazol-2-ylamino)methyl)pyrrolidine-1-carboxylate

Catalog No.: 
ACXNIT686
CAS No.: 
1420960-29-7
Molecular Formula: 
C17H23N3O2S
Molecular Weight: 
333.46
tert-butyl 3-((benzo[d]thiazol-2-ylamino)methyl)pyrrolidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-butyl 3-((benzo[d]thiazol-2-ylamino)methyl)pyrrolidine-1-carboxylate
IUPAC Nametert-butyl 3-((benzo[d]thiazol-2-ylamino)methyl)pyrrolidine-1-carboxylate
Molecular FormulaC17H23N3O2S
Molecular Weight333.46
SMILESCC(C)(C)OC(=O)N1CCC(CNC2=NC3=CC=CC=C3S2)C1
InChI KeyVZPCIETVYUFNIF-UHFFFAOYSA-N
Synonym1-Pyrrolidinecarboxylic acid, 3-[(2-benzothiazolylamino)methyl]-, 1,1-dimethylethyl ester
CAS No.1420960-29-7

Synthetic Route by SureRoute

1. ACXNIT686 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACADKE602 route compound structure diagram
    ACADKE602270912-72-6In Stock
  2. Plus
  3. ACQZGK630 route compound structure diagram
    ACQZGK630615-20-3In Stock
  4. Then
  5. ACXNIT686 route product structure diagram
    ACXNIT6861420960-29-7
Inquiry

2. ACXNIT686 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRDHS291 route compound structure diagram
    ACRDHS2912516-40-7In Stock
  2. Plus
  3. ACADKE602 route compound structure diagram
    ACADKE602270912-72-6In Stock
  4. Then
  5. ACXNIT686 route product structure diagram
    ACXNIT6861420960-29-7
Inquiry

3. ACXNIT686 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDNRV476 route compound structure diagram
    ACDNRV476141699-56-1In Stock
  2. Plus
  3. ACLZNR081 route compound structure diagram
    ACLZNR08194787-08-3In Stock
  4. Then
  5. ACXNIT686 route product structure diagram
    ACXNIT6861420960-29-7
Inquiry

Comments (0)